Olmesartan Medoxomil 40 mg and Chlorthalidone 12.5 mg is a combination medicine prescribed for the management of high blood pressure (hypertension). Olmesartan medoxomil belongs to the angiotensin II receptor blocker (ARB) group and helps relax blood vessels, while chlorthalidone is a thiazide-like diuretic that helps the body remove excess salt and water through urine. Together, these ingredients help control blood pressure and reduce the risk of complications associated with uncontrolled hypertension. Patients searching for Olmesartan Medoxomil 40 mg + Chlorthalidone 12.5 mg tablets in India should consult a qualified healthcare professional to confirm whether this combination is suitable for their condition. For product availability, pricing, and purchase enquiries, contact Steris Healthcare or consult an authorised pharmacy. Use this medicine strictly as prescribed and attend recommended blood pressure, kidney function, and electrolyte monitoring appointments.
कैसे उपयोग करें
Olmesartan Medoxomil 40 mg + Chlorthalidone 12.5 mg is a combination medicine prescribed to manage high blood pressure (hypertension). Olmesartan helps relax blood vessels, while chlorthalidone helps the body eliminate excess salt and water through urine. Together, they help control blood pressure. Use this medicine only under medical supervision and follow your doctor's instructions carefully.
1. Follow the Prescribed Dosage: Take Olmesartan Medoxomil 40 mg + Chlorthalidone 12.5 mg exactly as prescribed by your doctor. Do not increase, reduce, or change the dose independently.
2. Take It at the Recommended Time: Take the medicine at the same time each day. Your doctor may recommend taking it in the morning because chlorthalidone can increase urination.
3. Swallow with Water: Swallow the tablet with a glass of water. Follow the instructions on your product label regarding whether it should be taken with or without food.
4. Maintain Regular Use: Continue taking the medicine as prescribed, even if you feel well. High blood pressure often does not cause noticeable symptoms.
5. Missed Dose: If you miss a dose, follow your doctor's or pharmacist's advice. Do not take a double dose to compensate for a missed dose.
6. Monitor Blood Pressure: Check your blood pressure regularly and attend follow-up appointments to help your doctor assess how well the treatment is working.
7. Check Kidney Function and Electrolytes: Your doctor may recommend blood tests to monitor kidney function and electrolyte levels, including sodium and potassium.
8. Maintain Adequate Hydration: Drink fluids as advised by your doctor, particularly during hot weather or illness. Dehydration may increase the risk of low blood pressure and dizziness.
9. Inform Your Doctor About Other Medicines: Tell your healthcare professional about all medicines and supplements you take, especially other blood pressure medicines, lithium, and potassium supplements.
10. Follow Pregnancy Precautions: Olmesartan can cause serious harm to an unborn baby. If you become pregnant while taking this medicine, contact your doctor immediately for advice about stopping it and switching to a suitable alternative.
भंडारण
Store in cool and dry place
Important guidance
Safety advice
Check with your doctor
AlcoholConsult your doctor
Avoid or limit alcohol while taking Olmesartan Medoxomil 40 mg + Chlorthalidone 12.5 mg unless your doctor advises otherwise. Alcohol may enhance the blood-pressure-lowering effects of this medicine and increase the risk of dizziness, light-headedness, or fainting. Consult your healthcare professional before consuming alcohol, especially if you experience dehydration or low blood pressure during treatment.
PregnancyConsult your doctor
Olmesartan Medoxomil 40 mg + Chlorthalidone 12.5 mg should not be used during pregnancy because olmesartan can cause serious harm to an unborn baby. Inform your doctor if you are pregnant, planning pregnancy, or suspect you may be pregnant. If pregnancy occurs during treatment, contact your doctor immediately for advice about discontinuing olmesartan and switching to a suitable alternative.
BreastfeedingConsult your doctor
Olmesartan Medoxomil 40 mg + Chlorthalidone 12.5 mg should not be used during pregnancy because olmesartan can cause serious harm to an unborn baby. Inform your doctor if you are pregnant, planning pregnancy, or suspect you may be pregnant. If pregnancy occurs during treatment, contact your doctor immediately for advice about discontinuing olmesartan and switching to a suitable alternative.
DrivingConsult your doctor
Olmesartan Medoxomil 40 mg + Chlorthalidone 12.5 mg may cause dizziness, light-headedness, or weakness, especially when starting treatment or adjusting the dose. Chlorthalidone may also contribute to dehydration, which can affect alertness. Avoid driving or operating machinery if you experience these symptoms, and consult your doctor if they persist or interfere with daily activities.
KidneyConsult your doctor
Patients with kidney disease should use Olmesartan Medoxomil 40 mg + Chlorthalidone 12.5 mg under medical supervision. Olmesartan may affect kidney function, while chlorthalidone can alter fluid and electrolyte balance. Your doctor may recommend regular blood tests to monitor kidney function, sodium, and potassium levels. Inform your healthcare professional about existing kidney problems before starting treatment.
LiverConsult your doctor
Patients with liver disease should consult their doctor before taking Olmesartan Medoxomil 40 mg + Chlorthalidone 12.5 mg. Although olmesartan is not primarily metabolised by the liver, existing liver conditions may affect fluid balance and blood pressure regulation. Your doctor may recommend closer monitoring based on your medical history. Report symptoms such as yellowing of the skin or eyes, unusual fatigue, or abdominal discomfort promptly.
Clinical review pending
This page uses verified catalogue facts and responsible medicine-information rules. It supports awareness and does not replace a doctor's advice.
